Cell-derived microvesicles mediate the delivery of miR-29a/c to suppress angiogenesis in gastric carcinoma

Cancer Letters

Volumn 375, Issue 2, 2016, Pages 331-339

  Zhang, Haiyang ^a   Bai, Ming ^a   Deng, Ting ^a   Liu, Rui ^a   Wang, Xia ^a   Qu, Yanjun ^a   Duan, Jingjing ^a   Zhang, Le ^a   Ning, Tao ^a   Ge, Shaohua ^a   Li, Hongli ^a   Zhou, Likun ^a   Liu, Yuchen ^b   Ying, Guoguang ^a   Huang, Dingzhi ^a   Ba, Yi ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Angiogenesis; Gastric cancer; Microvesicle; MiR 29; VEGF

Indexed keywords

BIM PROTEIN; CD31 ANTIGEN; MICRORNA; MICRORNA 29A; MICRORNA 29C; UNCLASSIFIED DRUG; VASCULOTROPIN; MIRN29 MICRORNA, HUMAN; VASCULOTROPIN A;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIGEN EXPRESSION; ARTICLE; BASE PAIRING; BINDING SITE; CANCER INHIBITION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE DELIVERY SYSTEM; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; MEMBRANE MICROPARTICLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; PROTEIN SECRETION; STOMACH CANCER; STOMACH CARCINOMA; TUMOR MICROENVIRONMENT; UPREGULATION; ANIMAL; BIOSYNTHESIS; CARCINOMA; DRUG DELIVERY SYSTEM; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; STOMACH NEOPLASMS; TUMOR CELL LINE;

ANIMALS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CELL-DERIVED MICROPARTICLES; DRUG DELIVERY SYSTEMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICRORNAS; NEOVASCULARIZATION, PATHOLOGIC; STOMACH NEOPLASMS; TUMOR MICROENVIRONMENT; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84961259027     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2016.03.026     Document Type: Article

References (33)

1. Cocucci E., Racchetti G., Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol 2009, 19:43-51.
2. Thery C., Zitvogel L., Amigorena S. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol 2002, 2:569-579.
3. Cocucci E., Racchetti G., Rupnik M., Meldolesi J. The regulated exocytosis of enlargeosomes is mediated by a SNARE machinery that includes VAMP4. J. Cell Sci 2008, 121:2983-2991.
4. Zhang Y., Liu D., Chen X., Li J., Li L., Bian Z., et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell 2010, 39:133-144.
5. Alvarez-Erviti L., Seow Y., Yin H., Betts C., Lakhal S., Wood M.J. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol 2011, 29:341-345.
6. Zhang Y., Li L., Yu J., Zhu D., Li X., Gu H., et al. Microvesicle-mediated delivery of transforming growth factor beta1 siRNA for the suppression of tumor growth in mice. Biomaterials 2014, 35:4390-4400.
7. Skog J., Wurdinger T., van Rijn S., Meijer D.H., Gainche L., Sena-Esteves M., et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol 2008, 10:1470-1476.
8. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol 2007, 9:654-659.
9. Nakao S. Impact of anti-VEGF therapy on the cellular microenvironment in retinal angiogenesis. Nippon Ganka Gakkai Zasshi 2014, 118:943-952.
10. Finley S.D., Popel A.S. Effect of tumor microenvironment on tumor VEGF during anti-VEGF treatment: systems biology predictions. J. Natl Cancer Inst 2013, 105:802-811.
11. Chen W.L., Lin C.T., Lin N.T., Tu I.H., Li J.W., Chow L.P., et al. Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis. Invest. Ophthalmol. Vis. Sci 2009, 50:1659-1665.
12. Liu J.X., Wang X.G., Fu J., Luo R.C. Bevacizumab (Avastin) inhibits lung cancer-induced pulmonary microvascular angiogenesis. Nan Fang Yi Ke Da Xue Xue Bao 2006, 26:1027-1029. 1043.
13. He L.F., Wang T.T., Gao Q.Y., Zhao G.F., Huang Y.H., Yu L.K., et al. Stanniocalcin-1 promotes tumor angiogenesis through up-regulation of VEGF in gastric cancer cells. J. Biomed. Sci 2011, 18:39.
14. Hammes L.S., Tekmal R.R., Naud P., Edelweiss M.I., Kirma N., Valente P.T., et al. Up-regulation of VEGF, c-fms and COX-2 expression correlates with severity of cervical cancer precursor (CIN) lesions and invasive disease. Gynecol. Oncol 2008, 110:445-451.
15. Krzystek-Korpacka M., Matusiewicz M., Diakowska D., Grabowski K., Blachut K., Banas T. Up-regulation of VEGF-C secreted by cancer cells and not VEGF-A correlates with clinical evaluation of lymph node metastasis in esophageal squamous cell carcinoma (ESCC). Cancer Lett 2007, 249:171-177.
16. Adams J., Carder P.J., Downey S., Forbes M.A., MacLennan K., Allgar V., et al. Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen. Cancer Res 2000, 60:2898-2905.
17. He L., Hannon G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet 2004, 5:522-531.
18. Pelaez N., Carthew R.W. Biological robustness and the role of microRNAs: a network perspective. Curr. Top. Dev. Biol 2012, 99:237-255.
19. Zhang H., Yang H., Zhang C., Jing Y., Wang C., Liu C., et al. Investigation of microRNA expression in human serum during the aging process. J. Gerontol. A Biol. Sci. Med. Sci 2015, 70:102-109.
20. Liu R., Chen X., Du Y.Q., Yao W.Y., Shen L., Wang C., et al. Serum MicroRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin. Chem 2012, 58:610-618.
21. Liu R., Zhang C.N., Hu Z.B., Li G., Wang C., Yang C.H., et al. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur. J. Cancer 2011, 47:784-791.
22. Gong B.D., Xie Q., Wang L., Xiang X.G., Lin L.Y., Zhao G.D., et al. Real-time quantification of microRNAs in Huh7 cells by stem-loop reverse transcriptase polymerase chain reaction. Zhonghua Gan Zang Bing Za Zhi 2009, 17:603-606.
23. Chen C., Ridzon D.A., Broomer A.J., Zhou Z., Lee D.H., Nguyen J.T., et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005, 33:e179.
24. Malinda K.M. In vivo matrigel migration and angiogenesis assay. Methods Mol. Biol 2009, 467:287-294.
25. Akhtar N., Dickerson E.B., Auerbach R. The sponge/Matrigel angiogenesis assay. Angiogenesis 2002, 5:75-80.
26. Li J., Zhang Y., Liu Y., Dai X., Li W., Cai X., et al. Microvesicle-mediated transfer of microRNA-150 from monocytes to endothelial cells promotes angiogenesis. J. Biol. Chem 2013, 288:23586-23596.
27. Wang D., Fan Z., Liu F., Zuo J. Hsa-miR-21 and Hsa-miR-29 in tissue as potential diagnostic and prognostic biomarkers for gastric cancer. Cell. Physiol. Biochem 2015, 37:1454-1462.
28. Saari H., Lazaro-Ibanez E., Viitala T., Vuorimaa-Laukkanen E., Siljander P., Yliperttula M. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells. J. Control. Release 2015, 220(Pt B):727-737.
29. Liu Y., Zhao L., Li D., Yin Y., Zhang C.Y., Li J., et al. Microvesicle-delivery miR-150 promotes tumorigenesis by up-regulating VEGF, and the neutralization of miR-150 attenuate tumor development. Protein Cell 2013, 4:932-941.
30. Matkovich S.J., Van Booven D.J., Eschenbacher W.H., Dorn G.W. RISC RNA sequencing for context-specific identification of in vivo microRNA targets. Circ. Res 2011, 108:18-26.
31. Li L., Zhu D., Huang L., Zhang J., Bian Z., Chen X., et al. Argonaute 2 complexes selectively protect the circulating microRNAs in cell-secreted microvesicles. PLoS ONE 2012, 7:e46957.
32. Castanotto D., Rossi J.J. The promises and pitfalls of RNA-interference-based therapeutics. Nature 2009, 457:426-433.
33. El-Andaloussi S., Lee Y., Lakhal-Littleton S., Li J., Seow Y., Gardiner C., et al. Exosome-mediated delivery of siRNA in vitro and in vivo. Nat. Protoc 2012, 7:2112-2126.